Revenue: The sum of all revenue fields included for a company's operating activities.
Fulgent Genetics, Inc. (FLGT) had Revenue of $71.14M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$71.14M |
$-24.83M |
|
$49.65M |
|
$21.49M |
|
$105.76M |
|
$-34.62M |
|
$8.64M |
|
$-25.98M |
|
$-25.98M |
|
$-25.27M |
|
$-25.27M |
|
$-25.27M |
|
$-25.27M |
|
$-34.62M |
|
$-29.51M |
|
30.88M |
|
30.88M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$479.04M |
|
$116.34M |
|
$677.33M |
|
$1.16B |
|
$90.13M |
|
-- |
|
$22.08M |
|
$112.22M |
|
$1.04B |
|
$904.92M |
|
$1.04B |
|
28.85M |
|
| Cash Flow Statement Financials | |
$7.10M |
|
$10.94M |
|
$-44.83M |
|
$50.33M |
|
$23.53M |
|
$-26.79M |
|
$9.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.31 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
30.21% |
|
-48.67% |
|
-48.67% |
|
-- |
|
-36.52% |
|
-34.90% |
|
$1.90M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
1.03 |
|
87.65 |
|
-2.42% |
|
-2.79% |
|
-2.19% |
|
-2.42% |
|
$36.19 |
|
$0.06 |
|
$0.23 |
|